In AD patients, the brain-elevated activity of AChE is observed, which reduces the required Ach levels in the brain, impairs synaptic functions and eventually produces toxicity in neuronal cells, leading to brain damage, as well as memory loss and dementia [19]. The gene discussed is ACHE; the disease is Alzheimer disease.